Zydus Cadila gets approval from Mexican authority to test COVID-19 drug

"Clinical and regulatory development of Desidustat in COVID-19 is being executed in Mexico by Avant Santé Research Center S.A. de C.V., a leading contract research organisation headquartered in Monterrey, Mexico," Cadila Healthcare said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2CayFb2